1.Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases.
Tian Ping YU ; Jing HOU ; Ting Jie YANG ; Song LEI ; Mei YANG ; Yan Yan SU ; Yu Cheng CHEN ; Yu WU ; Xue Qin CHEN
Chinese Journal of Pathology 2023;52(7):671-677
Objective: To investigate the histological features and clinical manifestations in different types of cardiac amyloidosis to improve diagnostic accuracy. Methods: The histopathological features and clinical manifestations of 48 patients diagnosed with cardiac amyloidosis by Congo red stain and electron microscopy through endomyocardial biopsy were collected in West China Hospital of Sichuan University from January 2018 to December 2021. Immunohistochemical stains for immunoglobulin light chains (κ and λ) and transthyretin protein were carried out, and a review of literature was made. Results: The patients age ranged from 42 to 79 years (mean 56 years) and the male to female ratio was 1.1 to 1.0. The positive rate of endomyocardial biopsy was 97.9% (47/48), which was significantly higher than that of the abdominal wall fat (7/17). Congo red staining and electron microscopy were positive in 97.9% (47/48) and 93.5% (43/46), respectively. Immunohistochemical stains showed 32 cases (68.1%) were light chain type (AL-CA), including 31 cases of AL-λ type and 1 case of AL-κ type; 9 cases (19.1%) were transthyretin protein type (ATTR-CA); and 6 cases (12.8%) were not classified. There was no significant difference in the deposition pattern of amyloid between different types (P>0.05). Clinical data showed that ATTR-CA patients had less involvement of 2 or more organs and lower N-terminal pro-B-type natriuretic peptide (NT-proBNP) than the other type patients (P<0.05). The left ventricular stroke volume and right ventricular ejection fraction of ATTR-CA patients were better than the other patients (P<0.05). Follow-up data of 45 patients was obtained, and the overall mean survival time was 15.6±2.0 months. Univariate survival analysis showed that ATTR-CA patients had a better prognosis, while cardiac amyloidosis patients with higher cardiac function grade, NT-proBNP >6 000 ng/L, and troponin T >70 ng/L had a worse prognosis (P<0.05). Multivariate survival analysis showed that NT-proBNP and cardiac function grade were independent prognostic factors for cardiac amyloidosis patients. Conclusions: AL-λ is the most common type of cardiac amyloidosis in this group. Congo red staining combined with electron microscopy can significantly improve the diagnosis of cardiac amyloidosis. The clinical manifestations and prognosis of each type are different and can be classified based on immunostaining profile. However, there are still a few cases that cannot be typed; hence mass spectrometry is recommended if feasible.
Humans
;
Male
;
Female
;
Adult
;
Middle Aged
;
Aged
;
Prealbumin/metabolism*
;
Stroke Volume
;
Cardiomyopathies/pathology*
;
Congo Red
;
Ventricular Function, Right
;
Amyloidosis/pathology*
;
Prognosis
2.Histone methylation and diabetic cardiomyopathy.
Hao HONG ; Yu-Meng LI ; Xiang-Min MENG ; Tian DENG ; Bing-Mei ZHU
Acta Physiologica Sinica 2022;74(3):461-468
Histone methylation is one of the key post-translational modifications that plays a critical role in various heart diseases, including diabetic cardiomyopathy. A great deal of evidence has shown that histone methylation is closely related to hyperglycemia, insulin resistance, lipid and advanced glycation end products deposition, inflammatory and oxidative stress, endoplasmic reticulum stress and cell apoptosis, and these pathological factors play an important role in the pathogenesis of diabetic cardiomyopathy. In order to provide a novel theoretical basis and potential targets for the treatment of diabetic cardiomyopathy from the perspective of epigenetics, this review discussed and elucidated the association between histone methylation and the pathogenesis of diabetic cardiomyopathy in details.
Diabetes Mellitus
;
Diabetic Cardiomyopathies/pathology*
;
Histones
;
Humans
;
Methylation
;
Oxidative Stress
;
Protein Processing, Post-Translational
3.A novel phenotype with splicing mutation identified in a Chinese family with desminopathy.
Peng FAN ; Chao-Xia LU ; Xue-Qi DONG ; Di ZHU ; Kun-Qi YANG ; Ke-Qiang LIU ; Di ZHANG ; Ying ZHANG ; Xu MENG ; Hui-Qiong TAN ; Li-Tian YU ; Ke-Fei DOU ; Ya-Xin LIU ; Xue ZHANG ; Xian-Liang ZHOU
Chinese Medical Journal 2019;132(2):127-134
BACKGROUND:
Desminopathy, a hereditary myofibrillar myopathy, mainly results from the desmin gene (DES) mutations. Desminopathy involves various phenotypes, mainly including different cardiomyopathies, skeletal myopathy, and arrhythmia. Combined with genotype, it helps us precisely diagnose and treat for desminopathy.
METHODS:
Sanger sequencing was used to characterize DES variation, and then a minigene assay was used to verify the effect of splice-site mutation on pre-mRNA splicing. Phenotypes were analyzed based on clinical characteristics associated with desminopathy.
RESULTS:
A splicing mutation (c.735+1G>T) in DES was detected in the proband. A minigene assay revealed skipping of the whole exon 3 and transcription of abnormal pre-mRNA lacking 32 codons. Another affected family member who carried the identical mutation, was identified with a novel phenotype of desminopathy, non-compaction of ventricular myocardium. There were 2 different phenotypes varied in cardiomyopathy and skeletal myopathy among the 2 patients, but no significant correlation between genotype and phenotype was identified.
CONCLUSIONS
We reported a novel phenotype with a splicing mutation in DES, enlarging the spectrum of phenotype in desminopathy. Molecular studies of desminopathy should promote our understanding of its pathogenesis and provide a precise molecular diagnosis of this disorder, facilitating clinical prevention and treatment at an early stage.
Animals
;
Asian Continental Ancestry Group
;
Cardiomyopathies
;
genetics
;
pathology
;
Desmin
;
genetics
;
Electrocardiography
;
Female
;
Genotype
;
Humans
;
Male
;
Middle Aged
;
Muscular Dystrophies
;
genetics
;
pathology
;
Mutation
;
genetics
;
Pedigree
;
Phenotype
4.Inhibition of ER Stress by 2-Aminopurine Treatment Modulates Cardiomyopathy in a Murine Chronic Chagas Disease Model
Janeesh Plakkal AYYAPPAN ; Kezia LIZARDO ; Sean WANG ; Edward YURKOW ; Jyothi F NAGAJYOTHI
Biomolecules & Therapeutics 2019;27(4):386-394
Trypanosoma cruzi infection results in debilitating cardiomyopathy, which is a major cause of mortality and morbidity in the endemic regions of Chagas disease (CD). The pathogenesis of Chagasic cardiomyopathy (CCM) has been intensely studied as a chronic inflammatory disease until recent observations reporting the role of cardio-metabolic dysfunctions. In particular, we demonstrated accumulation of lipid droplets and impaired cardiac lipid metabolism in the hearts of cardiomyopathic mice and patients, and their association with impaired mitochondrial functions and endoplasmic reticulum (ER) stress in CD mice. In the present study, we examined whether treating infected mice with an ER stress inhibitor can modify the pathogenesis of cardiomyopathy during chronic stages of infection. T. cruzi infected mice were treated with an ER stress inhibitor 2-Aminopurine (2AP) during the indeterminate stage and evaluated for cardiac pathophysiology during the subsequent chronic stage. Our study demonstrates that inhibition of ER stress improves cardiac pathology caused by T. cruzi infection by reducing ER stress and downstream signaling of phosphorylated eukaryotic initiation factor (P-elF2α) in the hearts of chronically infected mice. Importantly, cardiac ultrasound imaging showed amelioration of ventricular enlargement, suggesting that inhibition of ER stress may be a valuable strategy to combat the progression of cardiomyopathy in Chagas patients.
2-Aminopurine
;
Animals
;
Cardiomyopathies
;
Chagas Disease
;
Endoplasmic Reticulum
;
Endoplasmic Reticulum Stress
;
Heart
;
Humans
;
Lipid Droplets
;
Lipid Metabolism
;
Mice
;
Mortality
;
Pathology
;
Peptide Initiation Factors
;
Trypanosoma cruzi
;
Ultrasonography
5.Effect of mitochondrial dysfunction in diabetic cardiomyopathy and intervention of traditional Chinese medicine.
China Journal of Chinese Materia Medica 2018;43(1):8-14
Diabetic cardiomyopathy (DCM) is characterized by left ventricular hypertrophy, myocardial fibrosis and diastolic dysfunction, which are uncorrelated with underlying coronary artery disease or hypertension. As an important metabolic organelle, mitochondria directly involve the process of cell growth, proliferation, signal transduction, apoptosis and so on. Recent studies have demonstrated a close correlation between the mitochondrial dysfunction and the pathogenesis of diabetic cardiomyopathy. The underlying effects of mitochondrial dysfunction in the progress of diabetic cardiomyopathy involve disturbed metabolism, oxidative stress, defective calcium handling, mitochondrial uncoupling, apoptosis, imbalance of mitochondrial quality control and regulation of MicroRNAs. Traditional Chinese medicines have been widely applied in clinic. Nowadays, more and more herbs of extracts of traditional Chinese medicines have been proved to ameliorate diabetic myocardial injury. Because the improvement of mitochondrial dysfunction has emerged as a promising therapeutic strategy, this review summarizes these effects of mitochondrial dysfunction in diabetic cardiomyopathy, and discusses the intervention studies of traditional Chinese medicine in the field, in expectation to provide new ideas for DCM prevention and treatment.
Diabetic Cardiomyopathies
;
drug therapy
;
pathology
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Medicine, Chinese Traditional
;
Mitochondria
;
pathology
;
Myocardium
6.Regulation of autophagy by tea polyphenols in diabetic cardiomyopathy.
Hui ZHOU ; Yan CHEN ; Shu-Wei HUANG ; Peng-Fei HU ; Li-Jiang TANG
Journal of Zhejiang University. Science. B 2018;19(5):333-341
OBJECTIVE:
To investigate the effect of tea polyphenols on cardiac function in rats with diabetic cardiomyopathy, and the mechanism by which tea polyphenols regulate autophagy in diabetic cardiomyopathy.
METHODS:
Sixty Sprague-Dawley (SD) rats were randomly divided into six groups: a normal control group (NC), an obesity group (OB), a diabetic cardiomyopathy group (DCM), a tea polyphenol group (TP), an obesity tea polyphenol treatment group (OB-TP), and a diabetic cardiomyopathy tea polyphenol treatment group (DCM-TP). After successful modeling, serum glucose, cholesterol, and triglyceride levels were determined; cardiac structure and function were inspected by ultrasonic cardiography; myocardial pathology was examined by staining with hematoxylin-eosin; transmission electron microscopy was used to observe the morphology and quantity of autophagosomes; and expression levels of autophagy-related proteins LC3-II, SQSTM1/p62, and Beclin-1 were determined by Western blotting.
RESULTS:
Compared to the NC group, the OB group had normal blood glucose and a high level of blood lipids; both blood glucose and lipids were increased in the DCM group; ultrasonic cardiograms showed that the fraction shortening was reduced in the DCM group. However, these were improved significantly in the DCM-TP group. Hematoxylin-eosin staining showed disordered cardiomyocytes and hypertrophy in the DCM group; however, no differences were found among the remaining groups. Transmission electron microscopy revealed that the numbers of autophagosomes in the DCM and OB-TP groups were obviously increased compared to the NC and OB groups; the number of autophagosomes in the DCM-TP group was reduced. Western blotting showed that the expression of LC3-II/I and Beclin-1 increased obviously, whereas the expression of SQSTM1/p62 was decreased in the DCM and OB-TP groups (P<0.05).
CONCLUSIONS
Tea polyphenols had an effect on diabetic cardiomyopathy in rat cardiac function and may alter the levels of autophagy to improve glucose and lipid metabolism in diabetes.
Animals
;
Autophagy
;
drug effects
;
Beclin-1
;
analysis
;
Blood Glucose
;
analysis
;
Body Weight
;
Diabetic Cardiomyopathies
;
drug therapy
;
pathology
;
physiopathology
;
Lipids
;
blood
;
Male
;
Myocardium
;
pathology
;
Polyphenols
;
pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Tea
;
chemistry
7.Left Ventricular Longitudinal Systolic Function in Septic Shock Patients with Normal Ejection Fraction: A Case-control Study.
Hong-Min ZHANG ; Xiao-Ting WANG ; Li-Na ZHANG ; Wei HE ; Qing ZHANG ; Da-Wei LIU ; null
Chinese Medical Journal 2017;130(10):1169-1174
BACKGROUNDSeptic cardiomyopathy is a common finding in septic shock patients. The accepted definition of septic cardiomyopathy is often based on the left ventricular ejection fraction (LVEF). The aim of this study was to determine whether the left ventricular longitudinal systolic function was more sensitive than the LVEF in heart function appraisal of septic shock patients.
METHODSThis was a case-control study conducted at a 40-bed Intensive Care Unit (ICU) of Peking Union Medical College Hospital. Septic shock patients admitted to the ICU were consecutively enrolled in the study group from March 1, 2016 to September 1, 2016. The control group was selected from nonsepsis patients who were admitted to the ICU and were comparable to the study group. Transthoracic echocardiography was performed to obtain the LVEF measurement, mitral annular plane systolic excursion (MAPSE), tissue Doppler velocity measurement of mitral annulus (Sa), and tricuspid annular plane systolic excursion.
RESULTSThe study group consisted of 45 septic shock patients. Another 45 nonsepsis patients were selected as the control group. There was no difference in the LVEF between the two groups (64.6% vs. 67.2%, t= -1.426, P= 0.161). MAPSE in the study group was much lower than in the control group (1.2 cm vs. 1.5 cm, t= -4.945, P< 0.001). Sa in the study group was also lower than in the control group (10.2 cm/s vs. 11.8 cm/s, t = -2.796, P= 0.014).
CONCLUSIONSCompared to the LVEF, longitudinal systolic function might be more sensitive in the detection of cardiac depression in septic shock patients. In the heart function appraisal of septic shock patients with a normal ejection fraction, more attention should be given to longitudinal function parameters such as MAPSE and Sa.
Aged ; Cardiomyopathies ; pathology ; physiopathology ; Case-Control Studies ; Echocardiography ; Echocardiography, Doppler ; Female ; Hemodynamics ; physiology ; Humans ; Intensive Care Units ; statistics & numerical data ; Male ; Middle Aged ; Shock, Septic ; pathology ; physiopathology ; Ventricular Function, Left ; physiology
8.Protective effect and mechanism of β-CM7 on renin angiotensin system & diabetic cardiomyopathy.
Kun WANG ; Dongning HAN ; Yujuan ZHANG ; Chao RONG ; Yuanshu ZHANG
Chinese Journal of Biotechnology 2016;32(2):195-203
This article aimed at exploring the effects and protective mechanism of β-CM7 on renin angiotensin system (RAS) in diabetic rats myocardial tissue. We divided 32 male SD rats into 4 groups: control group, diabetic model control group, insulin (3.7x10(-8) mol/d) treatment group and β-CM7 (7.5x10(-8) mol/d) treatment group. After 30 days, all rats were decapitated and myocardical tissues were collected immediately. After injection, β-CM7 could decrease the content of Ang II, increase the content of Angl-7. And β-CM7 could improve the mRNA of AT1 receptor and Mas receptor. β-CM7 also could improve the mRNA of ACE and ACE2, enhance the activity of ACE and ACE2. These data confirmed tli β-CM7 could activate ACE2-Angl-7-Mas axis, negative passage in RAS, to inhibit the expression ACE mnRiJA and protein in rat myocardium, alleviate the myocardial tissue damage induced by Ang II. The effect of β-CM7 on inhibiting myocardium damage might be related to ACE/ACE2 passageway.
Angiotensin II
;
metabolism
;
Animals
;
Diabetes Mellitus, Experimental
;
drug therapy
;
Diabetic Cardiomyopathies
;
drug therapy
;
Endorphins
;
pharmacology
;
Male
;
Myocardium
;
metabolism
;
pathology
;
Peptide Fragments
;
pharmacology
;
Peptidyl-Dipeptidase A
;
metabolism
;
RNA, Messenger
;
Rats
;
Rats, Sprague-Dawley
;
Receptor, Angiotensin, Type 1
;
metabolism
;
Receptors, G-Protein-Coupled
;
metabolism
;
Renin-Angiotensin System
9.A 40-Year-Old Man with Rashes and Palpitations.
Shan Xian LEE ; Yong Kwang TAY
Annals of the Academy of Medicine, Singapore 2016;45(6):264-266
Adult
;
Cardiomyopathies
;
diagnosis
;
etiology
;
Electrocardiography
;
Heart Block
;
diagnosis
;
etiology
;
Humans
;
Male
;
Sarcoidosis
;
complications
;
diagnosis
;
pathology
;
Skin Diseases
;
diagnosis
;
etiology
;
pathology
10.Cytoprotective effect of silymarin against diabetes-induced cardiomyocyte apoptosis in diabetic rats.
Muobarak J TUORKEY ; Nabila I EL-DESOUKI ; Rabab A KAMEL
Biomedical and Environmental Sciences 2015;28(1):36-43
OBJECTIVEThe beneficial effects of silymarin have been extensively studied in the context of inflammation and cancer treatment, yet much less is known about its therapeutic effect on diabetes. The present study was aimed to investigate the cytoprotective activity of silymarin against diabetes-induced cardiomyocyte apoptosis.
METHODSRats were randomly divided into: control group, untreated diabetes group and diabetes group treated with silymarin (120 mg/kg•d) for 10 d. Rats were sacrificed, and the cardiac muscle specimens and blood samples were collected. The immunoreactivity of caspase-3 and Bcl-2 in the cardiomyocytes was measured. Total proteins, glucose, insulin, creatinine, AST, ALT, cholesterol, and triglycerides levels were estimated.
RESULTSUnlike the treated diabetes group, cardiomyocyte apoptosis increased in the untreated rats, as evidenced by enhanced caspase-3 and declined Bcl-2 activities. The levels of glucose, creatinine, AST, ALT, cholesterol, and triglycerides declined in the treated rats. The declined levels of insulin were enhanced again after treatment of diabetic rats with silymarin, reflecting a restoration of the pancreatic β-cells activity.
CONCLUSIONThe findings of this study are of great importance, which confirmed for the first time that treatment of diabetic subjects with silymarin may protect cardiomyocytes against apoptosis and promote survival-restoration of the pancreatic β-cells.
Alanine Transaminase ; blood ; Animals ; Aspartate Aminotransferases ; blood ; Blood Glucose ; Cholesterol ; blood ; Creatinine ; blood ; Diabetes Mellitus, Experimental ; complications ; Diabetic Cardiomyopathies ; prevention & control ; Heart ; drug effects ; Immunohistochemistry ; Insulin ; blood ; Male ; Myocardium ; pathology ; Myocytes, Cardiac ; drug effects ; Rats ; Silymarin ; pharmacology ; Triglycerides ; blood

Result Analysis
Print
Save
E-mail